The worldwide epidemiology of type 2 diabetes mellitus???present and future perspectives, Nature Reviews Endocrinology, vol.14, issue.4, pp.228-236, 2012. ,
DOI : 10.1038/nrendo.2011.183
Pathogenesis of type 2 diabetes mellitus, Medical Clinics of North America, vol.88, issue.4, pp.787-835, 2004. ,
DOI : 10.1016/j.mcna.2004.04.013
Molecular Physiology and Genetics of NIDDM: Importance of Metabolic Staging, Diabetes Care, vol.15, issue.3, pp.369-395, 1992. ,
DOI : 10.2337/diacare.15.3.369
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus, Journal of Clinical Investigation, vol.104, issue.6, pp.787-794, 1999. ,
DOI : 10.1172/JCI7231
Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue, Nature Genetics, vol.20, pp.294-298, 1998. ,
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes, Diabetes, vol.49, issue.6, pp.969-974, 2000. ,
DOI : 10.2337/diabetes.49.6.969
Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM, Diabetes, vol.38, issue.5, pp.550-557, 1989. ,
DOI : 10.2337/diab.38.5.550
Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents, Diabetes, Obesity and Metabolism, vol.544, issue.(12), pp.699-718, 2008. ,
DOI : 10.1111/j.1463-1326.2007.00761.x
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., Journal of Clinical Investigation, vol.90, issue.4, pp.1323-1327, 1992. ,
DOI : 10.1172/JCI115997
Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy, Diabetes, vol.59, issue.11, pp.2697-2707, 2010. ,
DOI : 10.2337/db10-1032
Nuclear Magnetic Resonance Studies of Hepatic Glucose Metabolism in Humans, Recent Progress in Hormone Research, vol.56, issue.1, pp.219-237, 2001. ,
DOI : 10.1210/rp.56.1.219
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals, Nature Reviews Molecular Cell Biology, vol.307, issue.3, pp.141-151, 2011. ,
DOI : 10.1038/nrm3072
Beta- and Alpha-Cell Dysfunction in Type 2 Diabetes, Hormone and Metabolic Research, vol.36, issue.11/12, pp.775-781, 2004. ,
DOI : 10.1055/s-2004-826163
A Novel Role for Glucose 6-Phosphatase in the Small Intestine in the Control of Glucose Homeostasis, Journal of Biological Chemistry, vol.279, issue.43, pp.44231-44234, 2004. ,
DOI : 10.1074/jbc.R400011200
Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity, Diabetes & Metabolism, vol.36, issue.4, pp.257-262, 2010. ,
DOI : 10.1016/j.diabet.2010.05.001
Nutrient control of hunger by extrinsic gastrointestinal neurons, Trends in Endocrinology & Metabolism, vol.24, issue.8, pp.378-384, 2013. ,
DOI : 10.1016/j.tem.2013.04.005
URL : https://hal.archives-ouvertes.fr/inserm-00835940
Mu-Opioid Receptors and Dietary Protein Stimulate a Gut-Brain Neural Circuitry Limiting Food Intake, Cell, vol.150, issue.2, pp.377-388 ,
DOI : 10.1016/j.cell.2012.05.039
URL : https://hal.archives-ouvertes.fr/inserm-00737417
Protein Feeding Promotes Redistribution of Endogenous Glucose Production to the Kidney and Potentiates Its Suppression by Insulin, Endocrinology, vol.150, issue.2, pp.616-624, 2009. ,
DOI : 10.1210/en.2008-0601
Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits, Cell, vol.2014, issue.156, pp.84-96 ,
Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice: Induction of Renal and Intestinal Gluconeogenesis by Glucagon, Diabetes, vol.60, issue.12, pp.3121-3131, 2011. ,
DOI : 10.2337/db11-0571
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, Journal of Hepatology, vol.54, issue.3, pp.529-537, 2011. ,
DOI : 10.1016/j.jhep.2010.08.014
URL : https://hal.archives-ouvertes.fr/hal-00575314
FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response, Proceedings of the National Academy of Sciences of the United States of America, pp.10853-10858, 2009. ,
Effect of calorie restriction on in vivo glucose metabolism by individual tissues in rats, American Journal of Physiology, vol.276, pp.728-738, 1999. ,
Glycogen, pp.59-62, 1974. ,
DOI : 10.1016/B978-0-12-395630-9.50012-8
Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation, Histochemistry and Cell Biology, vol.38, issue.5, pp.555-565, 2007. ,
DOI : 10.1007/s00418-006-0263-5
Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability, FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, vol.17, pp.2299-2301, 2003. ,
Contribution of intestine and kidney to glucose fluxes in different nutritional states in rat, Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, vol.143, issue.2, pp.195-200, 2006. ,
DOI : 10.1016/j.cbpb.2005.11.007
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, Journal of Clinical Investigation, vol.118, issue.3, pp.829-838, 2008. ,
DOI : 10.1172/JCI34275
In vivo hepatic lipid quantification using MRS at 7 Tesla in a mouse model of glycogen storage disease type 1a, The Journal of Lipid Research, vol.54, issue.7, pp.2010-2022, 2013. ,
DOI : 10.1194/jlr.D033399
URL : https://hal.archives-ouvertes.fr/hal-00847703
Towards a molecular understanding of adaptive thermogenesis, Nature, vol.404, pp.652-660, 2000. ,
PPARs and the complex journey to obesity, Nature Medicine, vol.17, issue.4, pp.355-361, 2004. ,
DOI : 10.1161/01.ATV.0000103951.67680.B1
p38?? Mitogen-Activated Protein Kinase Is a Key Regulator in Skeletal Muscle Metabolic Adaptation in Mice, PLoS ONE, vol.4, issue.11, pp.38-7934, 2009. ,
DOI : 10.1371/journal.pone.0007934.s009
Targeting the AMPK pathway for the treatment of Type 2 diabetes, Frontiers in Bioscience, vol.Volume, issue.14, pp.3380-3400, 2009. ,
DOI : 10.2741/3460
URL : https://hal.archives-ouvertes.fr/inserm-00367501
Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor ??, Pharmacological Reviews, vol.61, issue.3, pp.373-393, 2009. ,
DOI : 10.1124/pr.109.001560
PGC-1??-mediated adaptations in skeletal muscle, Pfl??gers Archiv - European Journal of Physiology, vol.98, issue.6, pp.153-162, 2010. ,
DOI : 10.1007/s00424-010-0834-0
Regulation of Pancreatic ?? Cell Mass by Neuronal Signals from the Liver, Science, vol.322, issue.5905, pp.1250-1254, 2008. ,
DOI : 10.1126/science.1163971
Neuronal Pathway from the Liver Modulates Energy Expenditure and Systemic Insulin Sensitivity, Science, vol.312, issue.5780, pp.1656-1659, 2006. ,
DOI : 10.1126/science.1126010
Intestinal Gluconeogenesis Is a Key Factor for Early Metabolic Changes after Gastric Bypass but Not after Gastric Lap-Band in Mice, Cell Metabolism, vol.8, issue.3, pp.201-211, 2008. ,
DOI : 10.1016/j.cmet.2008.08.008
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy, Trends in Molecular Medicine, vol.11, issue.10, pp.473-479, 2005. ,
DOI : 10.1016/j.molmed.2005.08.002
Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid Metabolism, Cell Metabolism, vol.8, issue.6, pp.468-481, 2008. ,
DOI : 10.1016/j.cmet.2008.10.011
Hepatocyte Growth Factor Is a Novel Stimulator of Glucose Uptake and Metabolism in Skeletal Muscle Cells, Journal of Biological Chemistry, vol.283, issue.20, pp.13700-13706, 2008. ,
DOI : 10.1074/jbc.M707551200
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans Fibroblast growth factor 21 mediates specific glucagon actions, Nature Medicine Diabetes, vol.19, issue.62, pp.1453-1463, 2013. ,
Hepatic Fibroblast Growth Factor 21 Is Regulated by PPAR?? and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States, Cell Metabolism, vol.5, issue.6, pp.426-437, 2007. ,
DOI : 10.1016/j.cmet.2007.05.002
FGF21 reloaded: challenges of a rapidly growing field, Trends in Endocrinology & Metabolism, vol.22, issue.3, pp.81-86, 2011. ,
DOI : 10.1016/j.tem.2010.11.003
FGF-21 as a novel metabolic regulator, Journal of Clinical Investigation, vol.115, issue.6, pp.1627-1635, 2005. ,
DOI : 10.1172/JCI23606
Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity, Endocrinology, vol.150, issue.9, pp.4084-4093, 2009. ,
DOI : 10.1210/en.2009-0221
Fibroblast Growth Factor 21 Corrects Obesity in Mice, Endocrinology, vol.149, issue.12, pp.6018-6027, 2008. ,
DOI : 10.1210/en.2008-0816
Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21, Gastroenterology, vol.146, issue.2, pp.539-549, 2014. ,
DOI : 10.1053/j.gastro.2013.10.059
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice, Diabetes, vol.58, issue.1, pp.250-259, 2009. ,
DOI : 10.2337/db08-0392
Angiopoietin-related growth factor antagonizes obesity and insulin resistance, Nature Medicine, vol.106, issue.43, pp.400-408, 2005. ,
DOI : 10.1074/jbc.M105945200
Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?, PLoS ONE, vol.287, issue.1, p.22976, 2011. ,
DOI : 10.1371/journal.pone.0022976.g006
Novel insights into ChREBP regulation and function, Trends in Endocrinology & Metabolism, vol.24, issue.5, pp.257-268, 2013. ,
DOI : 10.1016/j.tem.2013.01.003
Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver, Journal of Hepatology, vol.56, issue.1, 2012. ,
DOI : 10.1016/j.jhep.2011.07.019
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism, Nature, vol.4, issue.7394, pp.333-338, 2012. ,
DOI : 10.1038/nature10986
The Peroxisome Proliferator-Activated Receptor ??/?? Agonist, GW501516, Regulates the Expression of Genes Involved in Lipid Catabolism and Energy Uncoupling in Skeletal Muscle Cells, Molecular Endocrinology, vol.17, issue.12, pp.2477-2493, 2003. ,
DOI : 10.1210/me.2003-0151
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome, Proceedings of the National Academy of Sciences of the United States of America, pp.15924-15929, 2003. ,
Peroxisome-Proliferator-Activated Receptor ?? Activates Fat Metabolism to Prevent Obesity, Cell, vol.113, issue.2, pp.159-170, 2003. ,
DOI : 10.1016/S0092-8674(03)00269-1
Cellular mechanisms of insulin resistance, Journal of Clinical Investigation, vol.106, issue.2, pp.171-176, 2000. ,
DOI : 10.1172/JCI10583
Discovery of TBC1D1 as an Insulin-, AICAR-, and Contraction-stimulated Signaling Nexus in Mouse Skeletal Muscle, Journal of Biological Chemistry, vol.283, issue.15, pp.9787-9796, 2008. ,
DOI : 10.1074/jbc.M708839200
Stimulation of Glucose Transport by AMP-activated Protein Kinase via Activation of p38 Mitogen-activated Protein Kinase, Journal of Biological Chemistry, vol.276, issue.44, pp.41029-41034, 2001. ,
DOI : 10.1074/jbc.M102824200
Intrahepatic Mechanisms Underlying the Effect of Metformin in Decreasing Basal Glucose Production in Rats Fed a High-Fat Diet, Diabetes, vol.51, issue.1, pp.139-143, 2002. ,
DOI : 10.2337/diabetes.51.1.139
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes, Diabetes, vol.51, issue.7, pp.2074-2081, 2002. ,
DOI : 10.2337/diabetes.51.7.2074
Metformin and the gut function In: Metformin mech. insights new appl, pp.31-40, 2008. ,
Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor ?? (LXR??) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type??1, Biochemical Journal, vol.114, issue.2, pp.249-254, 2010. ,
DOI : 10.1074/jbc.M801922200
Dissociating fatty liver and diabetes, Trends in Endocrinology & Metabolism, vol.24, issue.1, pp.4-12, 2013. ,
DOI : 10.1016/j.tem.2012.09.005
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration, Nature Medicine, vol.119, issue.6, pp.271-281, 2012. ,
DOI : 10.1074/jbc.M602497200
Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes, Journal of Biological Chemistry, vol.286, issue.40, pp.34533-34541, 2011. ,
DOI : 10.1074/jbc.M111.248591
Inventing new medicines: The FGF21 story, Molecular Metabolism, vol.3, issue.3, pp.221-229, 2014. ,
DOI : 10.1016/j.molmet.2013.12.003
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes, obese human subjects with type 2 diabetes, pp.333-340, 2013. ,
DOI : 10.1016/j.cmet.2013.08.005
Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody, Journal of Pharmacology and Experimental Therapeutics, vol.346, issue.2, pp.270-280, 2013. ,
DOI : 10.1124/jpet.113.204420
Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21, Journal of Peptide Science, vol.138, issue.Suppl 3, pp.383-393, 2012. ,
DOI : 10.1002/psc.2408
Outstanding Scientific Achievement Award Lecture 2011: Defeating Diabesity: The Case for Personalized Combinatorial Therapies, Diabetes, vol.61, issue.6, pp.1309-1314, 2012. ,
DOI : 10.2337/db12-0272